People held at the brand new Florida immigration detention center that officials have dubbed “Alligator Alcatraz” say worms ...

Trump’s Nobel Peace Prize nomination sparks global attention. Dive into the details of his recognition and the process behind ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

A Prime subscription is good for more than free shipping. Perks like cheaper gas, exclusive deals and discounts on groceries ...

This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition ...

Prime Medicine, Inc. (NYSE:PRME – Free Report) – Analysts at Wedbush issued their FY2029 earnings per share (EPS) estimates for Prime Medicine in a research report issued on Tuesday, March ...

Prime Medicine announced yesterday a new preclinical program for treating alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting lung and liver function. The announcement included ...

Prime Medicine announces promising preclinical results for a novel AATD treatment using advanced Prime Editing technology, aiming for clinical trials by mid-2026.

Prime Medicine is advancing its AATD program through the final stages of lead optimization and expects to file an IND and/or CTA filing in mid-2026. About AATD ...